Treace Medical Concepts (TMCI) Held by Superinvestors
TREACE MEDICAL CONCEPTS INC (TMCI) is currently held by 1 superinvestors tracked by InsiderSet, with a combined reported market value of approximately $192,234 based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.
Renaissance Technologies LLC is currently the largest disclosed institutional shareholder of TMCI tracked by InsiderSet, reporting ownership valued at approximately $192,234 in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $206,241, representing an estimated gain of +7.29% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed TMCI value among the investors covered in this analysis. Major shareholders include Renaissance Technologies LLC, and several other long-term asset managers with concentrated positions in TREACE MEDICAL CONCEPTS INC (TMCI).
This page ranks the largest institutional TMCI shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | Jim Simons | 0.00% | 48,300 | $192,234 | $206,241 | +$14,007 | +7.29% |
Frequently asked questions about TMCI
Who are the largest superinvestors holding TMCI?
The largest superinvestors holding TMCI in the latest SEC Form 13F filings include Renaissance Technologies LLC. InsiderSet ranks these superinvestors by their latest reported TMCI position.
What does the TMCI superinvestors page include?
This page tracks TMCI positions reported by a curated group of notable institutional investors and fund managers through SEC Form 13F. TREACE MEDICAL CONCEPTS INC (TMCI) on this page reflects disclosed 13F holdings among those superinvestors, not every institutional shareholder of the stock.
How many superinvestors hold TMCI?
InsiderSet currently tracks 1 superinvestors reporting TMCI holdings in the latest available 13F data. This is the curated set on this page, not the total number of institutions that own TMCI.
How much TMCI stock do superinvestors hold?
Superinvestors tracked by InsiderSet disclosed approximately $192,234 in TMCI holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value, and it covers the curated superinvestors on this page rather than every institutional filer.
When were TMCI superinvestor holdings last updated?
The latest TMCI superinvestor holdings on InsiderSet are based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time holdings.
Are superinvestor TMCI holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by these superinvestors as of the end of the reporting quarter. A superinvestor may have changed its TMCI position after the reporting date.
Are superinvestors buying or selling TMCI?
Buying and selling can be analyzed by comparing TMCI positions across consecutive 13F reporting periods. InsiderSet's TMCI Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View TMCI ownership changes.
How have superinvestor TMCI holdings changed over time?
InsiderSet tracks TMCI holdings among these superinvestors across multiple 13F reporting periods, so holder counts, reported value, and reported shares can be compared over time.